Dr Reddys Laboratories RDY
NYSE RDY
$13.10 +0.03 (+0.23%)
As of: Oct 19, 2026 · 3:59 PM EDT

Dr Reddys Laboratories (RDY) Invested Capital (2009 - 2026)

Updated

Dr Reddys Laboratories (RDY) reported Invested Capital of $4.87 billion for the quarter ended Jun 30, 2026, up 4.9% from $4.64 billion a year earlier but down 4.0% from the prior quarter.

Analysis

Dr Reddys Laboratories (RDY) Invested Capital (2009 - 2026) Analysis & Trends

For the year ended Mar 31, 2026, Dr Reddys Laboratories posted Invested Capital of $4.88 billion, up 8.5% from the prior year.

  • Invested Capital has increased for six consecutive years, with a five-year compound annual growth rate of 11.9% (years ended Mar 2021 to Mar 2026).
  • By year, Invested Capital came in at $4.49 billion in the year ended Mar 31, 2025 (+24.6%), $3.61 billion in the year ended Mar 31, 2024 (+15.4%), $3.13 billion in the year ended Mar 31, 2023 (+5.7%) and $2.96 billion in the year ended Mar 31, 2022 (+6.4%).
  • Five-year quarterly Invested Capital spans a low of $2.86 billion in the quarter ended Sep 30, 2022 and a high of $5.07 billion in the quarter ended Mar 31, 2026.
  • Year over year, Invested Capital has now increased in each of the last 13 quarters, with growth averaging 18.5% over the last eight quarters.
  • The high point for year-over-year Invested Capital in five years was the quarter ended Sep 30, 2024 (growth of 31.9%); the low point was the quarter ended Sep 30, 2022 (a decline of 1.4%).
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $5.07 billion (quarter ended Mar 31, 2026), $5.05 billion (quarter ended Dec 31, 2025) and $4.82 billion (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn 88.79 Bn
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn 134.01 Bn
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn 64.89 Bn
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn 95.89 Bn
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn 51.53 Bn
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn 82.72 Bn
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn 68.99 Bn
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn 38.08 Bn
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn 148.69 Bn
10 Dr Reddys Laboratories 10.90 Bn 10.27 Bn 396.53 Mn 4.86 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.86 Bn
Mar 31, 2026 4.85 Bn
Dec 31, 2025 5.01 Bn
Sep 30, 2025 4.74 Bn
Jun 30, 2025 4.77 Bn
Mar 31, 2025 4.49 Bn
Dec 31, 2024 4.36 Bn
Sep 30, 2024 4.27 Bn
Jun 30, 2024 3.91 Bn
Mar 31, 2024 3.60 Bn
Dec 31, 2023 3.51 Bn
Sep 30, 2023 3.22 Bn
Jun 30, 2023 3.15 Bn
Mar 31, 2023 2.98 Bn
Dec 31, 2022 2.93 Bn
Sep 30, 2022 2.80 Bn
Jun 30, 2022 2.91 Bn
Mar 31, 2022 2.96 Bn
Dec 31, 2021 2.94 Bn
Sep 30, 2021 2.89 Bn
API Access

Dr Reddys Laboratories Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=RDY&period=max&api_key=YOUR_API_KEY